fst
Senior Member (Voting Rights)
Post in thread 'Design and rationale of RECOVER-AUTONOMIC: A randomized platform trial evaluating interventions for Long COVID [POTS], 2026, Fudim et al.'
The IVIG arm of RECOVER Autonomic trial failed: https://recovercovid.org/news/lates...sults-shared-2026-aha-scientific-sessions-aas
Gamunex-C, a form of intravenous immunoglobulin (IVIG) that contains antibodies to help the body protect itself against infection from various diseases, does not have a significant impact on symptoms of severe postural orthostatic tachycardia syndrome (POTS) following COVID-19, according to results from the clinical trial RECOVER-AUTONOMIC (IVIG). Coordinated non-drug care also does not have a significant impact on...